OVERSTITCH? ENDOSCOPIC SUTURING SYSTEM (ESS) ESS-G02-160

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-09 for OVERSTITCH? ENDOSCOPIC SUTURING SYSTEM (ESS) ESS-G02-160 manufactured by Apollo Endosurgery, Inc..

Event Text Entries

[183975768] Initial medwatch sent to the fda. The device will not be returned for analysis, hence, analysis of the device is not possible. A review of the device labeling notes the following: the current overstitch? Endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "other-clinical outcome device related" as follows: warnings: only physicians possessing sufficient skill and experience in similar or the same techniques should perform endoscopic procedures. Users should be familiar with surgical procedures and techniques involving absorbable sutures before employing synthetic absorbable sutures for wound closure, as the risk of wound dehiscence may vary with the site of application and the suture material used. Ensure that there is sufficient space for the needle to open. Warning: do not introduce the device with the needle body in its open position. Adverse event: possible complications that may result from using the endoscopic suturing system include, but may not be limited to: pharyngeal, colonic and/or esophageal perforation esophageal, colonic and/or pharyngeal laceration intra-abdominal (hollow or solid) visceral injury the labeling is adequate as it addresses the reported complaints. The occurrence of this reported complaint for this product will be reviewed as appropriate in the complaints analysis meeting (cam).
Patient Sequence No: 1, Text Type: N, H10


[183975769] Reported as: patient presented fever 3. 5 weeks after esg procedure. Patient was diagnosed with liver abscess and was hospitalized and treated with antibiotics.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006722112-2020-00046
MDR Report Key9808744
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-09
Date of Report2020-02-11
Date of Event2020-02-09
Date Mfgr Received2020-02-11
Date Added to Maude2020-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDR. DAVID HOOPER
Manufacturer Street1120 S. CAPITAL OF TEXAS HWY BLDG 1, STE. 300
Manufacturer CityAUSTIN, TX
Manufacturer CountryUS
Manufacturer G1VIANT MEDICAL
Manufacturer Street5079 33RD STREET SE
Manufacturer CityGRAND RAPIDS, MI
Manufacturer CountryUS
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOVERSTITCH? ENDOSCOPIC SUTURING SYSTEM (ESS)
Generic NameSUTURING SYSTEM
Product CodeOCW
Date Received2020-03-09
Model NumberESS-G02-160
Catalog NumberESS-G02-160
Lot Number2019091049
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerAPOLLO ENDOSURGERY, INC.
Manufacturer Address1120 S. CAPITAL OF TEXAS HWY BLDG 1, STE. 300 AUSTIN, TX US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2020-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.